Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease.

Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease.

Item
http://www.wikidata.org/entity/Q37624819
The role of Merkel cell polyomavirus and other human polyomaviruses in emerging hallmarks of cancerEarly axonal loss accompanied by impaired endocytosis, abnormal axonal transport, and decreased microtubule stability occur in the model of Krabbe's disease.Lithium improves cell viability in psychosine-treated MO3.13 human oligodendrocyte cell line via autophagy activation.Cell-based high-throughput screening identifies galactocerebrosidase enhancers as potential small-molecule therapies for Krabbe's disease.Krabbe's leukodystrophy: Approaches and models in vitro.Lysosphingolipids and sphingolipidoses: Psychosine in Krabbe's disease.Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.Substrate reduction therapy for Krabbe's disease.Beyond Krabbe's disease: The potential contribution of galactosylceramidase deficiency to neuronal vulnerability in late-onset synucleinopathiesKrabbe disease: involvement of connexin43 in the apoptotic effects of sphingolipid psychosine on mouse oligodendrocyte precursors.A new hypothesis for Parkinson's disease pathogenesis: GTPase-p38 MAPK signaling and autophagy as convergence points of etiology and genomics
P2860

Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease.

Item
http://www.wikidata.org/entity/Q37624819
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Characterization and applicati ...... egenerative lysosomal disease.
@en
Characterization and applicati ...... egenerative lysosomal disease.
@nl
type
label
Characterization and applicati ...... egenerative lysosomal disease.
@en
Characterization and applicati ...... egenerative lysosomal disease.
@nl
prefLabel
Characterization and applicati ...... egenerative lysosomal disease.
@en
Characterization and applicati ...... egenerative lysosomal disease.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Characterization and applicati ...... egenerative lysosomal disease.
@en
P2093
P2860
P304
P31
P356
10.1016/J.YMGME.2013.09.011
P433
P478
P50
P577
P698
P921
P932